SecSonar.com

Myomo, Inc. (MYO)

Myomo, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Myomo, Inc. (MYO) is a Medical - Devices company based in US with a market capitalization of $41.5M. Revenue grew 25.7% year-over-year and free cash flow was negative at -$16.3M. This page tracks MYO's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 184 employees · IPO Jun 12, 2017

Valuation

Valuation & price

$0.91 · as of May 17, 2026 · -58.8% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

3.64

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$2.21$1.43$0.65Jul 25Dec 25Jul 26Jul 7, 25$2.04Jul 9, 25$2.21Jul 11, 25$2.08Jul 15, 25$2.00Jul 17, 25$2.05Jul 21, 25$2.10Jul 23, 25$2.15Jul 25, 25$2.11Jul 29, 25$1.98Jul 31, 25$1.93Aug 4, 25$1.96Aug 6, 25$1.85Aug 11, 25$1.76Aug 13, 25$1.05Aug 15, 25$0.97Aug 19, 25$1.14Aug 21, 25$1.12Aug 25, 25$1.09Aug 27, 25$1.12Aug 29, 25$1.05Sep 3, 25$1.03Sep 5, 25$1.00Sep 9, 25$0.95Sep 11, 25$0.90Sep 16, 25$0.82Sep 18, 25$0.84Sep 22, 25$0.85Sep 24, 25$1.04Sep 26, 25$0.93Sep 30, 25$0.89Oct 2, 25$0.92Oct 6, 25$0.98Oct 8, 25$1.18Oct 10, 25$1.08Oct 14, 25$1.16Oct 16, 25$1.08Oct 21, 25$1.12Oct 23, 25$1.05Oct 27, 25$1.07Oct 29, 25$0.97Oct 31, 25$0.93Nov 4, 25$0.84Nov 6, 25$0.82Nov 10, 25$0.92Nov 12, 25$0.85Nov 14, 25$0.82Nov 18, 25$0.72Nov 20, 25$0.72Nov 25, 25$0.84Nov 28, 25$0.89Dec 2, 25$0.89Dec 4, 25$1.02Dec 8, 25$1.08Dec 10, 25$1.07Dec 12, 25$1.05Dec 16, 25$1.04Dec 18, 25$0.90Dec 22, 25$0.97Dec 24, 25$1.02Dec 29, 25$0.92Jan 2, 26$0.99Jan 6, 26$1.02Jan 8, 26$0.98Jan 12, 26$0.98Jan 14, 26$0.93Jan 16, 26$0.96Jan 21, 26$0.97Jan 23, 26$0.91Jan 27, 26$0.94Jan 29, 26$0.85Feb 2, 26$0.88Feb 4, 26$0.81Feb 9, 26$0.81Feb 11, 26$0.80Feb 13, 26$0.82Feb 18, 26$0.78Feb 20, 26$0.73Feb 24, 26$0.65Feb 26, 26$0.78Mar 2, 26$0.75Mar 4, 26$0.80Mar 6, 26$0.80Mar 10, 26$0.68Mar 12, 26$0.69Mar 17, 26$0.72Mar 19, 26$0.72Mar 23, 26$0.71Mar 25, 26$0.70Mar 27, 26$0.70Mar 31, 26$0.68Apr 2, 26$0.67Apr 7, 26$0.68Apr 9, 26$0.70Apr 13, 26$0.73Apr 15, 26$0.80Apr 17, 26$0.86Apr 22, 26$0.82Apr 24, 26$0.82Apr 28, 26$0.82Apr 30, 26$0.86May 4, 26$0.86May 6, 26$0.85May 8, 26$0.83May 12, 26$0.78May 14, 26$0.89May 18, 26$0.84May 20, 26$0.91May 22, 26$1.04May 28, 26$1.09Jun 1, 26$1.16Jun 3, 26$1.10Jun 5, 26$1.28Jun 9, 26$1.31Jun 11, 26$1.37Jun 15, 26$1.35Jun 17, 26$1.42Jun 22, 26$1.25Jun 24, 26$1.18Jun 26, 26$1.03Jul 2, 26$1.05
$0.6452-week range$2.21
Loading valuation history…

Fundamentals

Key fundamentals

$41.5M

Market cap

25.7%

Revenue growth (YoY)

65.7%

Gross margin

-$16.3M

Free cash flow (USD)

$988.6K

Net debt

10.8%

Share dilution

0/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$1.1MFY 2017$1.6MFY 2018$2.4MFY 2019$3.8MFY 2020$7.6MFY 2021$13.9MFY 2022$15.6MFY 2023$19.2MFY 2024$32.6MFY 2025$40.9M
$1.1M$40.9M

Free cash flow by year

2016 → 2025

FY 2016$-3.2MFY 2017$-6.2MFY 2018$-9.7MFY 2019$-10.4MFY 2020$-9.1MFY 2021$-9.9MFY 2022$-10.3MFY 2023$-6.3MFY 2024$-4.7MFY 2025$-16.3M
-$3.2M-$16.3M

Gross margin by year

2021 → 2025

FY 202174.4%FY 202265.9%FY 202368.5%FY 202471.2%FY 202565.7%
74.4%65.7%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

4

Insider buys · 90 days

3

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 7, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventStockholder Meeting ResultsJun 29, 2026Filing
  • 8-K eventStockholder Meeting ResultsJun 26, 2026Filing
  • Insider buyInsider Buy $51KKIRK THOMAS F · Director · $50.8KJun 9, 2026Filing
  • Insider sellInsider Sell $78KMitchell Micah · Chief Commercial Officer · $77.7KJun 8, 2026Filing
  • Insider buyInsider Buy $25KKIRK THOMAS F · Director · $24.8KJun 1, 2026Filing
  • Insider sellInsider Sell $32KKovelman Harry · Chief Medical Officer · $32.2KMay 28, 2026Filing
  • Insider buyInsider Buy $174KManko Joseph M. Jr. · Director · $173.9KMay 18, 2026Filing
  • Insider buyInsider Buy $68KKIRK THOMAS F · Director · $68.2KMay 18, 2026Filing
  • Insider sellInsider Sell $78KMitchell Micah · Chief Commercial Officer · $77.7KMay 15, 2026Filing
  • 8-K eventDirector AppointmentMay 13, 2026Filing

Questions

Frequently asked questions

What is Myomo, Inc.'s market cap?

Myomo, Inc. (MYO) has a market capitalization of $41.5M.

What is MYO's P/E ratio?

A meaningful P/E ratio is not available for MYO — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is MYO's price-to-book (P/B) ratio?

MYO trades at 3.64 times book value per share.

Are insiders buying MYO stock?

Yes — SEC Form 4 filings show 4 open-market insider buys and 3 sells at Myomo, Inc. in the last 90 days.

Same arena

Related companies in Medical - Devices

TELA

TELA Bio, Inc.

$42.5M

NSPR

InspireMD, Inc.

$43.9M

ARAY

Accuray Incorporated

$44.9M

POAS

Phaos Technology Holdings (Caym

$34.8M

NMTC

NeuroOne Medical Technologies Corporation

$32.5M

CTSO

Cytosorbents Corporation

$31M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.